Home About Us Contact Us

 

Table of Content - Volume 6 Issue 3 - June 2017


A study of association of increased level of HbA1c with development of complications of diabetes mellitus at tertiary health care centre

 

Dilip Pandurang Patil

 

Assistant Professor, Department of Medicine, Krishna institute of Medical sciences " Deemed To Be University" Karad

Dist_ Satara-415539, Maharashtra, INDIA.

Email: patilhospitalkarad@gmail.com

 

REFERENCES

  1. World Health Organization. Diabetes facts. Available at: http://www.who.int/mediacentre/factsheets/fs312/en/index.html. Accessed December 13, 2007.
  2. World Health Organization. Diabetes action now booklet: a life-threatening condition. Available at: www.who.int/diabetes/BOOKLET_HTML/en/index3.html. Accessed December 13, 2007.
  3. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003; 26:917–932. 
  4. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia. 1991; 34:877–890. 
  5. Deshpande AD, Harris-Hayes M, Schootman M. Epidemiology of diabetes and diabetes-related complications. Phys Ther. 2008; 88:1254–1264. 
  6. Rahman S, Rahman T, Ismail AA, Rashid AR. Diabetes-associated macrovasculopathy: pathophysiology and pathogenesis. Diabetes Obes Metab. 2007; 9:767–780. 
  7. Davey Smith G, Bracha Y, Svendsen KH, et al. Incidence of type 2 diabetes in the Randomized Multiple Risk Factor Intervention Trial. Ann Intern Med. 2005; 142:313–322. 
  8. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001; 344:1343–1350. 
  9. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1989; 321:337–343. 
  10. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346:393–403. 
  11. W Todd Cade. Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting. Phys Ther. 2008 Nov; 88(11): 1322–1335.
  12. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;Sep 12;352(9131):837–853. 
  13. DCCT Study Group. The Effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993; Sep 30;329(14):977–986. 
  14. Jeffcoate SL. Diabetes control and complications: the role of glycated haemoglobin, 25 years on. Diabet Med. 2004; Jul;21(7):657–665. 
  15. Lind M, Odén A, Fahlén M, Eliasson B. A Systematic Review of HbA1c Variables Used in the Study of Diabetic Complications, Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2008:282–293.